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Objectives The transfer of adolescents with congenital heart disease from pediatric to adult care was examined. The aims
were to investigate where these adolescents received adult-centered care, to determine the proportion of pa-
tients with no follow-up and with no appropriate follow-up after leaving pediatric cardiology, and to explore the
determinants of no follow-up and no appropriate follow-up.
Background Even after successful treatment, many patients require lifelong cardiac surveillance by specialized practitioners.
Although guidelines describe the most appropriate level of follow-up, this is not always implemented in practice.
Methods A descriptive, observational study was performed, including 794 patients with congenital heart disease exam-
ined and/or treated at a tertiary care center.
Results Overall, 58 of the 794 patients included (7.3%) were not in follow-up. Cessation of follow-up was found in 2 of
74 patients with complex (2.7%), 31 of 448 patients with moderate (6.9%), and 25 of 272 patients with simple
(9.2%) heart defects. Moreover, 684 patients (86.1%) remained in specialized follow-up. According to interna-
tional guidelines, 81 patients (10.2%) did not receive the minimal level of cardiac care. Multivariable logistic
regression revealed that male sex and no prior heart surgery were associated with no follow-up. Male sex, no
prior heart surgery, and greater complexity of congenital heart disease were associated with no appropriate level
of cardiac follow-up.
Conclusions The proportion of patients in this study lost to follow-up was substantially lower than in other Western countries.
Because only patient-related factors were examined with respect to loss to follow-up, further examination of
patient-related, hospital-related, and healthcare-related determinants of lack of follow-up is needed.
(J Am Coll Cardiol 2011;57:2368–74) © 2011 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2010.11.068Congenital heart disease (CHD) is considered the most
common birth defect, with an incidence of 0.8% in
newborns (1). A substantial increase in life expectancy
has been observed in past decades, with approximately
90% of children born with CHD surviving into adult-
hood (2). Despite this improvement, patients with CHD
can experience residua or sequelae of the initial treatment
they received. Therefore, these defects are considered
“repaired” rather than “cured.” Hence, even after success-
ful primary treatment or surgery, many patients with
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tals Leuven, Leuven, Belgium; and the ‡Division of Congenital and Structural
Cardiology, University Hospitals Leuven, Leuven, Belgium. The authors have
reported that they have no relationships to disclose.Manuscript received July 23, 2010; revised manuscript received November 15,
2010, accepted November 30, 2010.CHD require lifelong cardiac surveillance by specialized
practitioners (3–5).
International guidelines and consensus statements describe
the most appropriate setting for follow-up of patients with
CHD. During childhood, these patients are most appropri-
ately followed up in pediatric programs. As they approach
adulthood, a timely transfer to an adult congenital heart disease
(ACHD) program is advocated (6–9). However, different
levels of adult-centered care exist. For instance, guidelines
categorize the level of ACHD care into 3 types: 1) specialist
care; 2) shared care; and 3) nonspecialist care (6). Specialist care
is follow-up given by specialized ACHD cardiologists and is
provided mainly at tertiary care centers. Shared care is
follow-up given by a general adult cardiologist in close collab-
oration with a CHD specialist. Nonspecialist care is follow-up
given by a general or community cardiologist, or a general
practitioner, with access to specialized care if needed (6).
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June 7, 2011:2368–74 Destinations of Transfer in Adolescents With CHDGuidelines describe which level of care is most appropri-
ate for each type of heart defect (5,6,9). Except for patients
with ligated and divided ductus arteriosus, all patients
should continue to receive cardiac care from a specialized
ACHD program, a local healthcare provider, or a collabo-
ration between local and specialist providers (9). Patients
with complex heart defects, such as cyanotic heart disease or
transposition of the great arteries, should receive checkups
every 6 to 12 months at a specialist center (5). Patients with
moderate-complexity lesions, such as tetralogy of Fallot,
atrioventricular septal defects, or coarctation of the aorta,
should have follow-up visits every 1 to 2 years (5). This is
preferably done at specialist centers (5) but can also be
undertaken at shared care facilities if the CHD course is
uncomplicated (6). Patients with simple heart defects, such
as small atrial septal defects or patent ductus arteriosus, need
medical checkups every 3 to 5 years, either in a nonspecial-
ized setting or at shared care facilities (5,6).
When patients with CHD transition from adolescence to
adulthood, they should be transferred to the most appro-
priate adult-focused facility without interruption (10).
However, studies in Canada (11,12), Germany (4), the
United Kingdom (13), and the United States (14) have
demonstrated that 21% to 76% of adolescents with CHD
are either lost to follow-up or experience lapses in care after
leaving pediatric cardiology. To the best of our knowledge,
no studies have comprehensively assessed the settings of
care in which adolescents with CHD receive care after
leaving pediatric cardiology. Therefore, the aims of the
present study were: 1) to determine the transfer destinations
of adolescents with CHD after leaving pediatric cardiology;
2) to determine the proportion of patients with no
follow-up and with no appropriate follow-up after leaving
pediatric cardiology; and 3) to explore the determinants of
no follow-up and no appropriate follow-up.
Methods
Setting. As part of the SWITCH2 (Self-Management and
ell-Being Improvements by Transitioning Adolescents
ith Chronic Disorders in Hospital and at Home) research
rogram (15), we conducted a descriptive, observational
tudy at the University Hospitals Leuven (Leuven, Bel-
ium). Belgium is a small country with a high population
ensity. Belgium currently has 7 tertiary care centers for
ediatric cardiology (16). The pediatric cardiology depart-
ent of the University Hospitals Leuven cares for 27% of
elgian patients with CHD. At this center, it is standard
ractice to transfer patients from pediatric cardiology to
dult-focused services when they reach 16 years of age,
nless they are medically unstable. Because the pediatric
HD and ACHD programs are located in the same building,
ransferring patients and medical information is easy. Further-
ore, both programs share 1 database for the clinical follow-up
f patients. Although transfer from pediatrics to adult-focused
are is well established, we do not have a formal transition crogram that prepares adolescents
or the transfer and to take respon-
ibility of their own care (17).
tudy population. Eligible pa-
ients were adolescents with
HD, which was defined as
tructural abnormalities of the
eart or intrathoracic great ves-
els that are actually or poten-
ially of functional significance
18); were born between 1984 and 1988; and had one or
ore cardiac consults in pediatric cardiology between 2000
nd 2004. The rationale for selecting these patients is that
hey had at least 1 outpatient visit at pediatric cardiology
uring adolescence, showing that they were not considered
o be cured in childhood. Because they were 21 years of age
r older in 2009, it could be assumed that all patients were
ared for in adult-focused care facilities. We excluded
atients who had died and those who had morphologically
ormal hearts, Wolff-Parkinson-White syndrome or cardiac
rrhythmia without structural defects, noncardiac congenital
efects, or pulmonary hypertension without structural
nomalies. Heart transplant recipients were also excluded.
n the basis of the center’s database and outpatient ap-
ointment lists, we were able to identify all patients who
et the inclusion and exclusion criteria. We included all
13 patients who were eligible for inclusion in this study.
ineteen patients had moved abroad and were excluded for
tatistical analysis because we could not obtain information
bout their current level of care. Hence, the final sample
omprised 794 patients. Sociodemographic and clinical
haracteristics of this sample are presented in Table 1.
efinitions. To categorize patients according to their pri-
ary heart defect, we used a modified version of the
ierarchy of heart defects developed by the CONCOR
CONgenital COR Vitia) project, an initiative to form a
ational registry of patients with CHD in the Netherlands
19). The modifications are detailed elsewhere (16). In
able 1, the heart defects are rank ordered according to the
ONCOR classification scheme. Furthermore, using the
riteria of Task Force 1 of the 32nd Bethesda Conference,
e categorized patients according to the complexity of their
eart defects (simple, moderate, and complex) (20).
Transfer destinations were defined on the basis of the 3
evels of CHD care described by Deanfield et al. (6):
pecialist care, shared care, and nonspecialist care. For the
urposes of the present study, we subdivided specialist care
nto pediatric cardiology care, ACHD care, and care at
atellite centers. The latter type of care refers to local
ospitals that have a CHD cardiologist-operated outpatient
linic. Shared care is defined as care performed by general
ardiologists who see patients with CHD but who send
eports to specialist centers for passing on information and
btaining clinical advice, if needed. Finally, nonspecialist
Abbreviations
and Acronyms
ACHD  adult congenital
heart disease
CHD  congenital heart
disease
CI  confidence interval
OR  odds ratioare is defined as care by general adult cardiologists who do
d
t
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provided by general practitioners.
For inferential statistics, patients were noted as having no
follow-up if they indicated that they were currently not in
Sociodemographic and Clinical Characteristicsof 794 Patients With CHDTable 1 Sociodemographic and Clinical Characteristicsof 794 Patients With CHD
Year of birth
1984 147 (18.5)
1985 126 (15.9)
1986 175 (22.0)
1987 158 (19.9)
1988 188 (23.7)
Sex
Male 421 (53.0)
Female 373 (47.0)
Primary CHD diagnosis
Hypoplastic left-heart syndrome 1 (0.1)
Univentricular physiology 14 (1.8)
Tetralogy of Fallot 72 (9.1)
Pulmonary atresia with VSD 0 (0)
Pulmonary atresia without VSD 2 (0.3)
DORV 18 (2.3)
DILV 1 (0.1)
Truncus arteriosus 3 (0.4)
TGA 31 (3.9)
Congenitally-corrected TGA 4 (0.5)
Coarctation of the aorta 90 (11.3)
AVSD 48 (6.0)
ASD type I 10 (1.3)
Ebstein malformation 3 (0.4)
Pulmonary valve abnormality 94 (11.8)
Aortic valve abnormality 106 (13.4)
Aortic abnormality 14 (1.8)
Left ventricular outflow tract obstruction 22 (2.8)
ASD type II 60 (7.6)
VSD 118 (14.9)
Mitral valve abnormality 51 (6.4)
Pulmonary vein abnormality 10 (1.3)
Other 22 (2.8)
Complexity of primary CHD diagnosis
Simple 272 (34.3)
Moderate 448 (56.4)
Complex 74 (9.3)
Prior interventions
No intervention 301 (37.9)
Only catheter intervention 60 (7.6)
Only surgical intervention 379 (47.7)
Both catheter and surgical intervention 54 (6.8)
Distance from home to University Hospitals Leuven (km)
0–49 235 (29.6)
50–99 407 (51.3)
100–149 125 (15.7)
150–199 26 (3.3)
200 1 (0.1)
Values are n (%).
ASD  atrial septal defect; AVSD  atrioventricular septal defect; CHD  congenital heart
isease; DILV  double-inlet left ventricle; DORV  double-outlet right ventricle; TGA  transposi-
ion of the great arteries; VSD  ventricular septal defect.cardiac follow-up or if they could not be contacted by mailor phone. Minimal levels of care were determined according
to the type and complexity of heart defects (5,6). The
guidelines of Task Force 4 of the 32nd Bethesda Confer-
ence (5), with a few exceptions, are applied by our pediatric
and ACHD cardiologists. Their expert opinions were used
to determine the appropriate minimal level of care for our
patients. Patients were noted as being in appropriate
follow-up if they received follow-up in a setting that was
minimally required or more specialized.
Procedure. For 676 patients, data on the setting of cardiac
follow-up were obtained from our hospital information
system. The remaining 137 patients received an information
letter, including an informed consent form, requesting
information about their current follow-up settings. We
telephoned patients as a reminder. Nine patients could not
be contacted by mail or telephone; they were untraceable.
Sex, year of birth, primary CHD diagnosis, CHD complex-
ity, prior cardiac surgery, prior catheter interventions, and
distance from patients’ homes to the University Hospitals
Leuven were determined on the basis of the patients’
medical records and additional data.
The institutional review board of the University Hospitals
Leuven approved the study protocol. The study was per-
formed in accordance with ethical standards, as described in
the 2002 Declaration of Helsinki.
Statistical analysis. Data were analyzed using SPSS ver-
sion 17.0 (SPSS, Inc., Chicago, Illinois). Nominal and
ordinal data are presented as absolute numbers and percents.
To determine sociodemographic and clinical variables asso-
ciated with no follow-up and no appropriate follow-up, we
performed multivariable logistic regression analysis using a
backward stepwise method. Results are reported as odds
ratios (ORs) and 95% confidence intervals (CIs). All tests
were 2-sided, and a p value of 0.05 was used as a cutoff for
statistical significance.
Results
Transfer destinations. Of the 794 patients included in the
study, a total of 627 adolescents with CHD (79.0%)
received follow-up at a tertiary care center. Of these, 613
(97.8%) were transferred to ACHD programs, and 14
(2.2%) were still in follow-up in pediatric cardiology (Fig. 1).
In addition, 57 patients (7.2%) received follow-up at a
satellite center. Hence, altogether, 86.1% of the patients
continued to receive specialist care when they reached young
adulthood. Fifty-two adolescents (6.5%) received cardiac
follow-up from a general adult cardiologist. In 29 of the 52
cases (55.8%), cardiologists sent examination reports to
CHD specialists; this type of follow-up was considered to
be shared care.
Forty-nine patients (6.2%) had no cardiac follow-up after
leaving pediatric cardiology, and 9 patients (1.1%) were
untraceable. Hence, 58 of the 794 patients included (7.3%)
were considered to be lost to follow-up. More specifically, 2
of the 74 patients with complex (2.7%), 31 of the 448
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with simple (9.2%) heart defects were no longer in cardiac
follow-up.
Minimal level of cardiac care. On the basis of primary
diagnosis and complexity of the congenital heart lesions, we
subdivided patients into 3 groups relating to the minimal
level of care they should receive. The first group consisted of
patients who should receive specialist care exclusively (Table 2).
This level of care can be performed at pediatric cardiology,
ACHD programs, or satellite centers. In all, 225 patients
(90%) received specialist care. Ten patients (4%) received
shared care, 9 patients (3.6%) received nonspecialist care, 5
patients (2%) were no longer in follow-up, and 1 patient
(0.4%) was untraceable. These latter levels of care were
suboptimal for these patients.
Among 247 patients who should receive specialist or
shared care, 215 patients (87%) received specialist care, and
7 patients (2.8%) received shared care (Table 3). Four
patients (1.6%) received nonspecialist care, 17 patients
(6.9%) were not in follow-up, and 4 patients (1.6%) were
untraceable.
Figure 1 Transfer Destinations in 794 Patients With CHD
ACHD  adult congenital heart disease; CHD  congenital heart disease.
Congenital Heart Defects Requiring Specialist CareTable 2 Congenital Heart Defects Requiring Specialist Care
Type of CHD Specialist Care
Hypoplastic left-heart syndrome 1
Univentricular heart 14
Pulmonary atresia without VSD 2
DORV 16
DILV 1
Truncus arteriosus 3
TGA 28
Congenitally corrected TGA 3
Coarctation of the aorta 80
Aortic abnormality 11
Tetralogy of Fallot 66
Proportion of patients in each setting of follow-up 90.0% (n  225) 4*Patients who did not receive the minimal level of cardiac care.
Abbreviations as in Table 1.Of the 297 patients for whom nonspecialist care would be
sufficient, 244 patients (82.2%) continued specialized
follow-up, 12 patients (4%) received shared care, and 10
patients (3.4%) received nonspecialist care. Twenty-seven
patients (9.1%) were not in cardiac follow-up, and 4 patients
(1.3%) were untraceable (Table 4).
Altogether, our data revealed that 81 patients (10.2%) did
not receive follow-up at the recommended level of care.
These patients were considered as receiving no appropriate
cardiac follow-up.
Factors associated with no follow-up and no appropriate
follow-up. We investigated the association between 5 so-
ciodemographic and clinical variables and no follow-up and
no appropriate follow-up: sex, prior heart surgery, prior
catheter intervention, complexity of heart defect, and dis-
tance from patients’ homes to our hospital. Independent
correlates of no cardiac follow-up after leaving pediatric
cardiology were male sex (OR: 1.80; 95% CI: 1.02 to 3.17)
and no prior heart surgery (OR: 5.97; 95% CI: 3.04 to
11.72). No appropriate level of cardiac follow-up after
leaving pediatric cardiology was associated with male sex
d Care Nonspecialist Care No Follow-Up Not Traceable
2*
2* 1*
1*
* 2* 3*
* 1*
* 3*
 10)* 3.6% (n  9)* 2.0% (n  5)* 0.4% (n  1)*Share
5
2
3
.0% (n
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(OR: 3.30; 95% CI: 1.88 to 5.77), and greater complexity of
CHD (OR: 1.61; 95% CI: 1.04 to 2.49).
Discussion
Continuing follow-up is important for many patients with
CHD. However, studies have shown that numerous pa-
tients are lost to follow-up or have lapses in care after
leaving pediatric cardiology (4,11–14). Furthermore, not all
patients receive the optimal level of care. Therefore, we
investigated the destinations of transfer in adolescents with
CHD, determined the proportion of patients with no
follow-up and no appropriate follow-up after leaving pedi-
atric cardiology, and sought correlates of no follow-up and
no appropriate follow-up.
Comparing our findings with published data, the situa-
tion at our center appears to be substantially better than in
other Western countries. To date, 5 studies have described
the proportion of patients lost to follow-up and/or experi-
encing lapses in care after leaving pediatric cardiology (21).
Reid et al. (11) investigated medical care in 360 patients age
19 to 21 years with complex CHD. These patients were
followed up in pediatric cardiology at the Hospital for Sick
Children in Toronto, Ontario, Canada, before the age of 18
years. The investigators defined successful transfer as pa-
tients attending 1 appointment at a Canadian ACHD
Congenital Heart Defects Requiring Specialist or Shared CareTable 3 Congenital Heart Defects Requiring Specialist or Share
Type of CHD Specialist Care
AVSD 45
ASD type I 7
Ebstein malformation 3
Associated pulmonary valve abnormality 31
Left ventricular outflow tract obstruction 19
VSD 29
Associated mitral valve abnormality 9
Pulmonary vein abnormality 10
Isolated pulmonary valve abnormality 50
Other 12
Proportion of patients in each setting of follow-up 87.0% (n  215)
*Patients who did not receive the minimal level of cardiac care.
Abbreviations as in Table 1.
Congenital Heart Defects for Which Nonspecialist Care Is SufficienTable 4 Congenital Heart Defects for Which Nonspecialist Care
Type of CHD Specialist Care
Isolated aortic valve abnormality 47
Associated ASD type II 27
Isolated ASD type II 27
VSD repaired without residua 72
Isolated mitral valve abnormality 25
Associated aortic valve abnormality 40
Other 6
Proportion of patients in each setting of follow-up 82.2% (n  244)*Patients who did not receive the minimal level of cardiac care.
Abbreviations as in Table 1.center. In this study, 53% of the patients did not successfully
transfer, and 25% had no cardiac appointments after the
age of 18 years.
At the German Heart Center in Munich, Germany,
Wacker et al. (4) evaluated the rate and outcomes of adults
with CHD lost to follow-up. Patients were selected from
the CHD program registry (n 10,500). This population
included a broad spectrum of CHD. Loss to follow-up was
defined as patients’ failing to return for follow-up visits to
their center for 5 years. The investigators found that
76% of patients were lost to follow-up.
In another study, de Bono and Freeman (13) assessed 59
patients with coarctation of the aorta. This study was
performed in the United Kingdom at a local ACHD clinic
without on-site cardiothoracic surgery or pediatric cardiol-
ogy facilities. Patients who were in follow-up in the ACHD
clinic at the time of the study, but who were not being seen
at other cardiac clinics for a period of 2 years, were
considered lost to follow-up. Thirty-nine percent of the
patients had 1 episode of loss to follow-up.
Yeung et al. (14) conducted a study in Denver, Colorado,
that determined the proportion of patients (with moderate
or complex heart defects) who experienced lapses in medical
care after leaving pediatric cardiology. A lapse in care was
defined as a 2-year interval between leaving pediatric
cardiology and presentation at the ACHD clinic. In 63% of
re
d Care Nonspecialist care No Follow-Up Not Traceable
1* 2*
1 1* 1*
1 1* 3* 1*
3*
2 3* 2*
2*
3 1* 3*
1*
(n  7) 1.6% (n  4)* 6.9% (n  17)* 1.6% (n  4)*
ufficient
d Care Nonspecialist Care No Follow-Up Not Traceable
2 4 2*
1 1 2*
1 1*
2 2 4* 2*
2 2 9* 2*
3 1 7*
1 2*
n  12) 3.4% (n  10) 9.1% (n  27)* 1.3% (n  4)*d Ca
Share
2.8%t Is S
Share
4.0% (
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duration of 10 years.
Mackie et al. (12) conducted a population-based investi-
gation in Quebec, Canada, of 643 patients diagnosed with
CHD before 6 years of age and currently 22 years old. Lack
of follow-up, defined as the absence of an outpatient
assessment by a cardiologist, was retrieved from the physi-
cian billing database. This study revealed that 61% of the
patients failed to receive cardiac follow-up after their 18th
birthdays. Subgroup analyses showed that 47% of patients
with moderate or complex heart defects (mild defects were
excluded) were lost to follow-up after their 18th birthdays,
whereas 21% of adult patients with complex lesions (mild
and moderate defects were excluded) were lost to follow-up.
Generally, a wide variation in percents of patients lost to
follow-up or those with lapses of care has been observed.
However, these data are not comparable, because the studies
differed substantially in terms of definition of loss to
follow-up, study population, inclusion criteria, recruitment
setting (pediatric cardiology, ACHD clinic, or population
based), data collection methods (database or retrospective
evaluation), and follow-up period. This likely resulted in
underestimation and overestimation of the proportions of
patients lost to follow-up. For example, de Bono and
Freeman (13) and Yeung et al. (14) recruited patients at
ACHD clinics. By doing so, they underestimated the
problem of loss to follow-up, because patients not under
medical surveillance were excluded in their studies. In
contrast, Wacker et al. (4) included all patients recorded in
their center’s registry and considered patients to be lost to
follow-up if they did not have checkups at that specific
center. Consequently, they probably overestimated loss to
follow-up, because a substantial number of patients with
mild defects may not have needed ongoing cardiac follow-
up, and some patients received cardiac follow-up at other
centers.
Regardless of the limited comparability across these
studies, our study demonstrated a considerably lower pro-
portion of loss to follow-up. There are several explanations.
First, at our center, pediatric cardiology and an ACHD
program are located in the same building. Hence, patients
do not have to go to another hospital when being transferred
to adult care. Second, pediatric and ACHD cardiologists at
our center use the same medical records, hospital informa-
tion system, and database. This facilitates the transfer of
medical information. Third, to keep patients under medical
surveillance, our clinic sends outpatient visit reminders to
patients, according to the proposed frequency of follow-up
visits. Nonresponding patients will receive up to 3 remind-
ers. Fourth, Belgium has a compulsory health insurance
system, covering almost the entire population. Therefore,
noninsurance or underinsurance is no barrier for patients
wanting to obtain the care needed. Fifth, there is no
mandatory general practitioner gate-keeping system in Bel-
gium, resulting in easy access to tertiary care, which in-
creases the accessibility of CHD care. Finally, Belgium is asmall country with a high population density. Hence, the
distances from patients’ homes to specialized centers are
relatively short. In our sample, 80% of the patients lived
100 km (62 mi) from our hospital.
To what extent these factors affected our findings is
unknown. However, obviously not only patient-related
factors but also healthcare system–related and hospital-
related factors have an impact on successful continuation
of cardiac follow-up when patients reach adulthood.
Indeed, the availability and structure of CHD programs
will have an impact on how care is provided (22,23).
To address this issue, we are currently preparing the
INTERCHANGE (INTERnational study on the Con-
tinuation of Heart health checks in young Adults with
coNGEnital heart disease) study, an international study
on healthcare-related, hospital-related, and patient-
related determinants of lack of cardiac follow-up in
adulthood. This will be an observational study using a
multilevel approach, with data collection at 3 levels:
country, center, and patient. Across Europe and North
America, 20 centers will participate, including about
7,500 patients.
In the present study, we focused on the minimal level of
care. We found that 10.2% of our patients did not receive
follow-up at the minimally recommended level. However,
we also observed that the level of care exceeded the
guidelines in many patients (5). For instance, in the group of
patients for whom nonspecialist care is sufficient (Table 4),
86.3% of patients received specialist or shared care. If the
ACHD program is saturating, there would be an opportu-
nity to discharge patients with mild heart defects to lower
levels of care. So far, we have not done so, because our
pediatric cardiology and ACHD programs are located in a
teaching hospital. In terms of training of cardiology fellows,
it is considered to be appropriate to have exposure to the
entire spectrum of CHD.
Study limitations. First, this study was conducted at 1
tertiary center with a specific structure and located in a
particular healthcare system. Thus, our results are not
generalizable. Second, this study mainly applied the Task
Force 4 recommendations for cardiac follow-up (5). These
recommendations are not completely consistent with, for
instance, European guidelines (6). Application of European
guidelines would likely result in different findings. Third,
only patient-related correlates of no follow-up and no appro-
priate follow-up were investigated, leaving healthcare system–
related and hospital–related factors unaddressed. The planned
INTERCHANGE study, however, will address these factors.
Conclusions
Only 7.3% of our patients with CHD were no longer in
cardiac follow-up after leaving pediatric cardiology. Of the
patients with complex, moderate, and simple CHD, 2.7%,
6.9%, and 9.2%, respectively, were no longer in follow-up.
According to international guidelines, 10.2% of our patients
11
1
1
1
1
1
1
1
1
2
2
2
2
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level. No follow-up was associated with male sex and no
prior heart surgery. No appropriate follow-up was correlated
with male sex, no prior heart surgery, and greater complexity
of CHD. Our results are substantially better than those in
other Western countries. Firm explanations for the observed
differences will be determined in our future study of
healthcare-, hospital-, and patient-related determinants.
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